Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-31

Clinical Trial Update: Efficacy and Safety Study of Sodium Tanshinone IIA Sulfonate on Pulmonary Hypertension [Phase 2, Phase 3]

View source ↗

Summary

This document describes an efficacy and safety study of Sodium Tanshinone IIA Sulfonate for pulmonary hypertension, including Phase 2 and Phase 3 with current s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium Tanshinone IIA Sulfonate (Sodium tanshinone IIA sulfonate)

Snippet

Sponsor: The First Affiliated Hospital of Guangzhou Medical University | Conditions: Pulmonary Hypertension, Pulmonary Arterial Hypertension | Phase 2, Phase 3 | Status: UNKNOWN